
Darunavir Ethanolate APIyog ib qho tshuaj tiv thaiv kab mob uas feem ntau siv los kho tus kab mob HIV-1 kab mob. Nws yog ib qho protease inhibitor (PI), ib chav kawm ntawm cov tshuaj uas ua haujlwm los ntawm inhibiting HIV protease, ib qho enzyme tsim nyog rau tus kab mob kev loj hlob. Hauv kev siv tshuaj tiv thaiv kab mob siab heev lossis kev sib xyaw ua ke tshuaj tiv thaiv kab mob, darunavir feem ntau yog siv ua ke nrog lwm cov tshuaj tiv thaiv kab mob. Kev sib xyaw ua ke no yog tsim los txo cov kab mob kis, nce CD4+ T-cell suav, thiab txhim kho tag nrho lub neej zoo rau cov neeg nyob nrog HIV. Darunavir ethanolate yog ib qho prodrug, uas txhais tau hais tias nws tau metabolized rau hauv nws daim ntawv nquag hauv lub cev.
Shaanxi Medibridge Biotech Co., Ltd. tsom rau kev muab cov khoom siv tshuaj raw khoom thiab kev tshawb fawb- siv cov khoom sib txuas. Peb txhawb cov neeg siv khoom nrog kev ruaj khov zoo, kev sib txuas lus meej meej, kev xaiv ntim tau yooj yim, thiab cov ntaub ntawv - cuam tshuam txog kev txhawb nqa rau theem sib txawv.
COA
|
|
||
|
Khoom npe |
CAS Nr |
Batch Number |
|
Darunavir Ethanolate API |
635728-49-3 |
MB2606130045 |
|
Hnub tim tsim khoom |
Hnub Soj Ntsuam |
Hnub Kawg |
|
2026/6/13 |
2026/6/15 |
2028/6/15 |
|
Qauv Qty Puag |
Ntim |
Txoj Kev Xeem |
|
100 KGS |
25KG / nruas |
HPLC |
|
|
||
|
Yam khoom |
Txuj |
Cov txiaj ntsig |
|
Qhov tshwm sim |
Dawb hmoov |
Ua raws |
|
tsw |
Yam ntxwv |
Ua raws |
|
Assay |
Ntau dua lossis sib npaug li 98.0% |
98.67% |
|
Particle Loj |
100% dhau 80 mesh |
Ua raws |
|
Moisture |
<5.0% |
Ua raws |
|
Tshauv Ntsiab Lus |
<4.0% |
Ua raws |
|
Solvent Residue |
Eur. Pharm |
Ua raws |
|
Total Heavy Metals |
<10 ppm |
Ua raws |
|
Arsenic |
<1.0 ppm |
Ua raws |
|
Coj |
<1.0 ppm |
Ua raws |
|
Mercury |
<0.5 ppm |
Ua raws |
|
DDT |
<0.2ppm |
Ua raws |
|
E. Coli |
Tsis zoo |
Tsis zoo |
|
GMO Status |
Ua raws |
GMO Dawb |
|
Irradiation |
Ua raws |
Irradiation Dawb |
|
Xaus |
Cov batch ua raws li IN-HOUSE tus qauv |
|
|
|
||
Mechanism of Action: Thaiv Viral Maturation
Darunavir inhibits HIV-1 protease, enzyme uas tshem tawm cov kab mob Gag thiab Gag-Pol polyproteins thaum lub sij hawm loj hlob tuaj. Thaum cov cleavage no raug thaiv, cov kab mob tshiab uas tsim tawm tseem tsis paub tab thiab tsis muaj kab mob ib txwm muaj. Cov khoom sib xyaw ua haujlwm nyob rau theem maturation ntawm viral lub neej voj voog; nws tsis ncaj qha tshem tawm latent viral reservoirs.
Darunavir tau tsim los nrog cov yam ntxwv ntawm cov qauv uas ua raws li cov qauv ntawm cov protease substrate qhov kev hloov pauv ntawm lub xeev. Nws bis -tetrahydrofuran pab pawg tsim cov kev cuam tshuam tseem ceeb nrog lub nraub qaum ntawm qhov chaw ua haujlwm protease. Cov kev sib cuam tshuam no pab piav qhia vim li cas darunavir tuaj yeem khaws cov haujlwm tawm tsam qee qhov protease variants, txawm hais tias kev tawm tsam tseem tuaj yeem txhim kho.

Antiviral Activity thiab Resistance Research

Kev ntsuas tshuaj tiv thaiv kab mob yuav tsum txuas ntxiv mus dhau qhov kev ntsuam xyuas siv cov tsiaj qus-hom HIV-1. Rau cov kab mob kis tau rau yav dhau los protease inhibitors, kev txhais lus yuav tsum muaj kev tiv thaiv genotype, phenotypic susceptibility, keeb kwm kev kho mob, thiab ua tiav cov tshuaj tiv thaiv kab mob.
Protease hloov pauv cuam tshuam nrog kev txo qis darunavir muaj xws li V11I, V32I, L33F, I47V, I50V, I54L / M, T74P, L76V, I84V, thiab L89V. Lawv cov teebmeem nyob ntawm kev sib xyaw ua ke ntawm kev hloov pauv thiab cov kab mob kis kab mob nyob ib puag ncig. Cov ntsiab lus tshawb fawb muaj txiaj ntsig muaj xws li inhibitory concentration, fold pauv txheeb ze rau cov tsiaj qus- hom kab mob, muaj peev xwm kis tau tus kab mob, thiab qhov cuam tshuam ntawm kev sib hloov ua ke. API purity ib leeg tsis tuaj yeem tsim kom muaj kev cuam tshuam hauv cov kab mob tiv thaiv kab mob.
Khoom -Lub Xeev Kev Tshawb Fawb ntawm Ethanolate
Hauv darunavir ethanolate, ethanol tau muab tso rau hauv cov qauv siv lead ua. Nws cov khoom ruaj khov-lub xeev tus kheej tuaj yeem hloov pauv thaum cov khoom raug cuam tshuam rau qhov sib txawv ntawm qhov kub, qhov av noo, lossis qhov hnyav ib puag ncig. Cov kev tshawb fawb luam tawm tau piav qhia txog kev hloov pauv uas cuam tshuam nrog ethanolate, hydrate, thiab amorphous cov ntaub ntawv, suav nrog kev hloov pauv cuam tshuam nrog desolvation lossis high humidity. Cov kev hloov pauv zoo li no tuaj yeem cuam tshuam rau kev ua thiab kev sib cais.
Yog li ntawd, ib yam khoom uas sau tias "Darunavir Ethanolate" yuav tsum yog tus yam ntxwv tshaj li qhov tsos thiab chromatographic soj ntsuam. Cov cuab yeej cuam tshuam suav nrog hmoov X-ray diffraction (XRPD) rau daim ntawv siv lead ua, ntsuas ntsuas ntsuas kub (TGA) thiab qhov sib txawv scanning calorimetry (DSC) rau thermal cwj pwm, validated txoj kev rau ethanol thiab dej cov ntsiab lus, thiab dynamic vapor sorption (DVS) rau cov av noo teb.

Synthesis, crystallization, thiab impurity tswj

Darunavir yog ib tug complex molecule nrog cov kev cai stereochemical. Cov txheej txheem kev tshawb fawb yuav tsum tshuaj xyuas cov kev xaiv ntawm nws cov chiral yam ntxwv tseem ceeb, coupling efficiency, thiab seb qhov kawg crystallization tsis tu ncua ua rau lub hom phiaj ethanolate daim ntawv.
Ib qho impurity- tswj lub tswv yim yuav tsum xav txog:
- Txheej txheem-txog impurities: tsis muaj kev cuam tshuam nruab nrab, cov tshuaj tiv thaiv los ntawm- khoom, thiab stereoisomeric impurities;
- Cov khoom degradation: cov tebchaw tsim nyob rau hauv cov cua sov, av noo, lub teeb, oxidative, los yog kev daws teeb meem;
- Cov kuab tshuaj thiab inorganic impurities: residual processing solvents, catalysts, and related elemental impurities.
Muaj peev xwm tshawb nrhiav cov lus qhia
|
Kev tshawb fawb cheeb tsam |
Lo lus nug tseem ceeb |
|
Cov qauv thiab kev tiv thaiv |
Yuav ua li cas tshwj xeeb protease mutation kev sib txuas ua ke hloov kev khi thiab kev tiv thaiv kab mob? |
|
Khoom - lub xeev hloov pauv |
Yuav ua li cas cov av noo, qhov kub thiab txias, thiab mechanical processing cuam tshuam ethanolate tus kheej? |
|
Txoj kev tsom xam |
Yuav ua li cas thiaj li muaj zog -cov ntsiab lus moiety, impurities, crystal- txuam ethanol, thiab dej ntsuas tau ntseeg tau? |
|
Kev tsim qauv |
Yuav ua li cas crystal form thiab particle loj cuam tshuam tiav lawm - cov khoom dissolution thiab raug? |
|
Kev ruaj ntseg |
Puas yog daim ntawv thov ntim txwv cov kuab tshuaj pauv hloov pauv, noo noo, thiab hloov pauv cov yam ntxwv tseem ceeb? |
|
Txheej txheem scale -up |
Puas muaj crystallization, pom, thiab ziab kom qhuav tuaj yeem xa cov khoom siv rau hauv cov khoom siv? |
FAQ
Vim li cas ethanolate solvate daim ntawv nyiam rau API tsim thiab kev tshawb fawb?
Daim ntawv ethanolate solvate crystalline muaj kev txhim kho cov khoom muaj zog- lub xeev ruaj khov, zoo dua bioavailability, thiab cov yam ntxwv zoo sib xws rau kev sim tshuaj.
Dab tsi yog Darunavir Ethanolate API siv rau hauv kev tshawb fawb?
Nws ua haujlwm raws li cov cuab yeej tshawb fawb muaj zog rau kev tshawb nrhiav HIV-1 protease inhibition, cov txheej txheem tiv thaiv kab mob, thiab cov txheej txheem biology ntawm retroviral enzymes.
Lub hom phiaj khi profile thiab qhov tshwj xeeb ntawm qhov sib xyaw no yog dab tsi?
Nws nthuav tawm picomolar binding affinity rau cov tsiaj qus-hom HIV-1 protease thiab tseem muaj zog tiv thaiv ntau yam tshuaj tiv thaiv kab mob mutant.
Dab tsi yog cov kuab tshuaj zoo tshaj plaws rau kev rov tsim dua Darunavir Ethanolate rau cell -raws li kev soj ntsuam?
Nws yog yooj yim soluble nyob rau hauv dimethyl sulfoxide (DMSO) thiab ethanol, uas yog pom zoo rau kev npaj siab -concentration stock solutions.
Cim npe nrov: darunavir ethanolate api, Tuam Tshoj darunavir ethanolate api manufacturers, lwm tus, Hoobkas



